BioCentury | Mar 9, 2015
Company News

Optos, Nikon deal

...Nikon will acquire Optos for 340p per share in cash, or about L259.3 million ($399.3 million...
...in cash, or about L259.3 million ($399.3 million). The price is a 30% premium to Optos’...
...for the nine months ended Dec. 31, 2014. Optos had 2014 revenues of $168.9 million. Optos plc...
BioCentury | Oct 14, 2013
Company News

Ablynx antibodies news

...on single-domain antibody fragments. Fellner is chairman of Consort Medical plc (LSE:CSRT, Hemel Hempstead, U.K.), Optos plc...
BioCentury | Oct 7, 2013
Company News

Ablynx splitting CEO, chairman roles

...independent chairman. Fellner is chairman of drug delivery company Consort Medical plc (LSE:CSRT); ophthalmic company Optos plc...
BioCentury | Oct 17, 2011
Company News

Opko, Optos deal

...Optos' Optos Inc. subsidiary completed its acquisition of Opko's ophthalmic instrumentation business for $17.5 million in...
...for $17.5 million in cash (see BioCentury, Sept. 26). Opko Health Inc. (NYSE:OPK), Miami, Fla. Optos plc...
BioCentury | Sep 26, 2011
Company News

Opko, Optos deal

...Opko will sell its ophthalmic instrumentation business to Optos' Optos Inc. subsidiary for $17.5 million in...
...to close next quarter. Optos plans to combine Opko's OCT SLO retinal imaging technology with Optos'...
...protocols or combination products (see BioCentury, March 9, 2009). Opko Health Inc. (NYSE:OPK), Miami, Fla. Optos plc...
BioCentury | Aug 15, 2011
Company News

Guided Therapeutics, Konica Minolta Holdings Inc. deal

Guided Therapeutics began a U.S. feasibility study under an amended 2010 deal with Konica Minolta's Konica Minolta Opto Inc. optics unit to use Guided Therapeutics' LightTouch technology to co-develop a product to detect and monitor...
BioCentury | Apr 4, 2011
Company News

Guided Therapeutics, Konica Minolta Holdings Inc. deal

Konica Minolta's Konica Minolta Opto Inc. optics unit extended by one year to 2012 a previously extended 2009 deal to use Guided Therapeutics' LightTouch technology to co-develop and market non-invasive diagnostics for lung and esophageal...
BioCentury | May 10, 2010
Company News

Guided Therapeutics, Konica Minolta Holdings Inc. deal

Konica Minolta's Konica Minolta Opto Inc. optics unit extended by one year a May 2009 deal to use Guided Therapeutics' LightTouch technology to co-develop and market non-invasive diagnostics for lung and esophageal cancers. Guided Therapeutics...
BioCentury | Feb 8, 2010
Clinical News

Taxcor Plus regulatory update

Opto's Eurocor GmbH subsidiary received CE mark approval in the EU for its Taxcor Plus stent to treat coronary artery disease (CAD). Taxcor is a paclitaxel-coated stent. Opto Circuits (India) Ltd. (NSE:OPTOCIRCUI; BSE:532391), Bangalore, India...
BioCentury | Jun 8, 2009
Company News

ProStrakan management update

...plc (LSE:PSK), Galashiels, U.K. Business: Musculoskeletal, Endocrine Hired: Allan Watson as CFO, currently CFO at Optos plc...
Items per page:
1 - 10 of 15
BioCentury | Mar 9, 2015
Company News

Optos, Nikon deal

...Nikon will acquire Optos for 340p per share in cash, or about L259.3 million ($399.3 million...
...in cash, or about L259.3 million ($399.3 million). The price is a 30% premium to Optos’...
...for the nine months ended Dec. 31, 2014. Optos had 2014 revenues of $168.9 million. Optos plc...
BioCentury | Oct 14, 2013
Company News

Ablynx antibodies news

...on single-domain antibody fragments. Fellner is chairman of Consort Medical plc (LSE:CSRT, Hemel Hempstead, U.K.), Optos plc...
BioCentury | Oct 7, 2013
Company News

Ablynx splitting CEO, chairman roles

...independent chairman. Fellner is chairman of drug delivery company Consort Medical plc (LSE:CSRT); ophthalmic company Optos plc...
BioCentury | Oct 17, 2011
Company News

Opko, Optos deal

...Optos' Optos Inc. subsidiary completed its acquisition of Opko's ophthalmic instrumentation business for $17.5 million in...
...for $17.5 million in cash (see BioCentury, Sept. 26). Opko Health Inc. (NYSE:OPK), Miami, Fla. Optos plc...
BioCentury | Sep 26, 2011
Company News

Opko, Optos deal

...Opko will sell its ophthalmic instrumentation business to Optos' Optos Inc. subsidiary for $17.5 million in...
...to close next quarter. Optos plans to combine Opko's OCT SLO retinal imaging technology with Optos'...
...protocols or combination products (see BioCentury, March 9, 2009). Opko Health Inc. (NYSE:OPK), Miami, Fla. Optos plc...
BioCentury | Aug 15, 2011
Company News

Guided Therapeutics, Konica Minolta Holdings Inc. deal

Guided Therapeutics began a U.S. feasibility study under an amended 2010 deal with Konica Minolta's Konica Minolta Opto Inc. optics unit to use Guided Therapeutics' LightTouch technology to co-develop a product to detect and monitor...
BioCentury | Apr 4, 2011
Company News

Guided Therapeutics, Konica Minolta Holdings Inc. deal

Konica Minolta's Konica Minolta Opto Inc. optics unit extended by one year to 2012 a previously extended 2009 deal to use Guided Therapeutics' LightTouch technology to co-develop and market non-invasive diagnostics for lung and esophageal...
BioCentury | May 10, 2010
Company News

Guided Therapeutics, Konica Minolta Holdings Inc. deal

Konica Minolta's Konica Minolta Opto Inc. optics unit extended by one year a May 2009 deal to use Guided Therapeutics' LightTouch technology to co-develop and market non-invasive diagnostics for lung and esophageal cancers. Guided Therapeutics...
BioCentury | Feb 8, 2010
Clinical News

Taxcor Plus regulatory update

Opto's Eurocor GmbH subsidiary received CE mark approval in the EU for its Taxcor Plus stent to treat coronary artery disease (CAD). Taxcor is a paclitaxel-coated stent. Opto Circuits (India) Ltd. (NSE:OPTOCIRCUI; BSE:532391), Bangalore, India...
BioCentury | Jun 8, 2009
Company News

ProStrakan management update

...plc (LSE:PSK), Galashiels, U.K. Business: Musculoskeletal, Endocrine Hired: Allan Watson as CFO, currently CFO at Optos plc...
Items per page:
1 - 10 of 15